AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2019
Mar 5, 2019
30339_dirs_2019-03-05_38e13a7c-a8d0-46cb-bf34-50ab0ca30985.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2019-03-01
Reporting Person: Abraham Silji (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-01 | Common Stock | A | 477.00 | $106.14 | Acquired | 4642.00 | Direct |
Footnotes
F1: Bonus & Incentive share grant
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27